Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finerenone in Heart Failure With Preserved Ejection Fraction (FIN-HF-LVS)
NCT07830940Phase 4Not yet recruiting
- Sponsor
- Assiut University
- Start
- Sep 2026
- Primary completion
- Sep 2027
01
Overview
A Phase 4 trial of finerenone in heart failure with preserved ejection fraction (HFpEF), sponsored by Assiut University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
finerenone
03
Conditions
heart failure with preserved ejection fraction (HFpEF)
Beyond the preview
Go deeper on NCT07830940.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07830940.